FDA Inspection
PHC- Las Cruces, Inc.PHC- Las Cruces, Inc. – FDA Inspection, Feb 15, 2013
Record Details
This FDA Inspection record concerns PHC- Las Cruces, Inc., with an inspection on February 15, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- PHC- Las Cruces, Inc.
- Inspection Date
- February 15, 2013
- Product Type
- Biologics
View Company Profile
ID · 150fe2ef-906a-40d9-a74c-43b2d892de3e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 818860
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 600.12(a)Maintenance - concurrence
Full citation text and observation details available on the Dashboard.
Other FDA inspections of PHC- Las Cruces, Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| May 20, 2026 | Not classified | Denver District Office | |
| January 12, 2023 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| July 18, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 28, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 18, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for PHC- Las Cruces, Inc.
- FDA Inspection 1319904 - 2026-05-20
- FDA Inspection 1194861 - 2023-01-12
- FDA Inspection 1099345 - 2019-07-18
- FDA Inspection 1028084 - 2017-07-28
- FDA Inspection 906141 - 2014-11-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.